HIMS Hims & Hers Health, Inc.
Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1773751 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY29.8%
TTM net income YoY-242.6%
TTM EPS YoY-256.6%
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR—
Margins
Gross margin63.8%
Operating margin-8.1%
Net margin-6.7%
FCF margin0.3%
EBITDA margin-4.3%
Returns
ROE-40.8%
ROA-6.6%
ROIC (approx.)—
Asset turnover0.99x
Leverage & solvency
Liabilities / assets90.0%
Debt / equity0.00x
Current ratio0.92x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.94x
Accruals ratio-12.8%
Payout ratio—
Capex / revenue6.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $890.37M | $753.21M | $608.10M | $617.82M | $598.98M | $544.83M | $586.01M | $481.14M |
| Cost of revenue | $381.17M | $272.41M | $211.32M | $173.38M | $156.92M | $128.64M | $155.32M | $111.60M |
| Gross profit | $509.20M | $480.80M | $396.79M | $444.44M | $442.06M | $416.20M | $430.69M | $369.54M |
| SG&A expense | $151.48M | $165.38M | $109.67M | $76.17M | $80.68M | $67.27M | $48.61M | $48.03M |
| Operating income | -$66.15M | -$97.19M | -$78.32M | $9.19M | $11.81M | $26.72M | $57.90M | $18.60M |
| Pretax income | -$46.25M | -$92.63M | -$101.55M | $18.35M | $12.22M | $32.85M | $60.49M | $22.29M |
| Income tax | -$13.21M | -$6.34M | -$9.44M | -$2.25M | -$3.55M | -$9.65M | $11.01M | -$3.73M |
| Net income | -$33.04M | -$86.29M | -$92.11M | $20.60M | $15.77M | $42.51M | $49.48M | $26.02M |
| EBITDA | -$27.94M | -$67.72M | -$56.37M | $27.28M | $29.48M | $37.19M | $66.17M | $24.66M |
| EPS (basic) | -0.14 | -0.37 | -0.40 | — | 0.07 | 0.19 | 0.22 | — |
| EPS (diluted) | -0.14 | -0.37 | -0.40 | — | 0.06 | 0.17 | 0.20 | — |
| Weighted avg. shares (diluted) | 233.82M | 231.75M | 228.36M | — | 248.68M | 256.78M | 246.61M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $605.60M | $609.81M | $222.27M | $228.62M | $345.78M | $1.12B | $273.74M | $221.44M |
| Short-term investments | $106.62M | $231.24M | $528.61M | $348.88M | $283.97M | $20.03M | $48.94M | $79.67M |
| Receivables | $427.85M | $375.29M | $149.62M | $32.15M | — | — | — | $6.10M |
| Inventory | $107.85M | $87.78M | $79.07M | $80.13M | $105.99M | $141.80M | $76.10M | $64.43M |
| Current assets | $1.32B | $1.38B | $1.05B | $767.64M | $845.26M | $1.36B | $446.96M | $395.83M |
| Goodwill | $1.11B | $1.10B | $342.84M | $278.32M | $259.24M | $117.75M | $117.75M | $112.73M |
| Intangibles | $397.26M | $422.81M | $261.03M | $196.12M | $194.93M | $40.66M | $43.43M | $43.41M |
| Total assets | $3.55B | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | $891.71M | $707.54M |
| Current liabilities | $1.44B | $1.48B | $618.78M | $404.43M | $450.79M | $272.23M | $280.36M | $221.37M |
| Total liabilities | $3.19B | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | $342.45M | $230.82M |
| Shareholders' equity | $355.30M | $324.07M | $446.17M | $540.93M | $580.98M | $562.70M | $549.26M | $476.72M |
| Cash flow statement | ||||||||
| Operating cash flow | $65.39M | -$35.94M | $89.36M | $61.31M | $148.72M | -$19.12M | $109.09M | $86.39M |
| Capital expenditure | $39.40M | $32.30M | $36.30M | $63.90M | $69.30M | $50.40M | $59.00M | $26.90M |
| Free cash flow | $25.99M | -$68.24M | $53.06M | -$2.59M | $79.42M | -$69.52M | $50.09M | $59.48M |
| Investing cash flow | -$55.42M | $84.54M | -$15.45M | -$83.68M | -$887.40M | -$21.09M | -$32.80M | -$17.21M |
| Financing cash flow | -$18.92M | $341.76M | -$77.88M | -$97.52M | -$39.01M | $889.17M | -$23.02M | -$13.65M |
| Depreciation & amortization | $38.21M | $29.48M | $21.95M | $18.09M | $17.67M | $10.46M | $8.28M | $6.06M |
| Stock-based compensation | $64.48M | $42.12M | $36.86M | $34.49M | $40.17M | $35.73M | $24.86M | $24.35M |
| Share buybacks | — | — | — | $80.48M | $9.48M | $0 | $0 | $5.00M |
Free plan shows the latest 8 periods; Pro shows all 30 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.